Added to YB: 2024-03-27
Pitch date: 2024-03-02
ATRC [bullish]
AtriCure, Inc.
+13.12%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally.
Market Cap
$1.8B
Pitch Price
$36.28
Price Target
N/A
Dividend
N/A
EV/EBITDA
-142.66
P/E
-46.87
EV/Sales
3.50
Sector
Health Care Equipment and Supplies
Category
growth
Show full summary:
TimesSquare U.S. Small Cap Growth Strategy Added to Portfolio Holding: AtriCure, Inc.
ATRC: -19% QTD on obesity drug threat to CV devices. Beat and raise overshadowed by market fears, but we added to our position. Bullish despite noise.
Read full article (1 min)